tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2022 Aug 2;10(8):1237.
doi: 10.3390/vaccines10081237.
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
Saverio Giuseppe Parisi[SUP] 1 [/SUP], Carlo Mengoli[SUP] 1 [/SUP], Monica Basso[SUP] 1 [/SUP], Ilaria Vicenti[SUP] 2 [/SUP], Francesca Gatti[SUP] 1 [/SUP], Renzo Scaggiante[SUP] 3 [/SUP], Lia Fiaschi[SUP] 2 [/SUP], Federica Giammarino[SUP] 2 [/SUP], Marco Iannetta[SUP] 4 [/SUP], Vincenzo Malagnino[SUP] 4 [/SUP], Daniela Zago[SUP] 1 5 [/SUP], Filippo Dragoni[SUP] 2 [/SUP], Maurizio Zazzi[SUP] 2 [/SUP]
Affiliations
Abstract
We report the time course of neutralizing antibody (NtAb) response, as measured by authentic virus neutralization, in healthcare workers (HCWs) with a mild or asymptomatic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection diagnosed at the onset of the pandemic, with no reinfection throughout and after a three-dose schedule of the BNT162b2 mRNA vaccine with an overall follow-up of almost two years since infection. Forty-eight HCWs (median age 47 years, all immunocompetent) were evaluated: 29 (60.4%) were asymptomatic. NtAb serum was titrated at eight subsequent time points: T1 and T2 were after natural infection, T3 on the day of the first vaccine dose, T4 on the day of the second dose, T5, T6, and T7 were between the second and third dose, and T8 followed the third dose by a median of 34 days. NtAb titers at all postvaccination time points (T4 to T8) were significantly higher than all those at prevaccination time points (T1 to T3). The highest NtAb increase was following the first vaccine dose while subsequent doses did not further boost NtAb titers. However, the third vaccine dose appeared to revive waning immunity. NtAb levels were positively correlated at most time points suggesting an important role for immunogenetics.
Keywords: BNT162b2 mRNA vaccine; COVID-19; authentic virus neutralization; healthcare workers; long-term follow-up; mild or asymptomatic SARS-CoV-2 infection; no reinfection; third vaccine dose.
. 2022 Aug 2;10(8):1237.
doi: 10.3390/vaccines10081237.
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
Saverio Giuseppe Parisi[SUP] 1 [/SUP], Carlo Mengoli[SUP] 1 [/SUP], Monica Basso[SUP] 1 [/SUP], Ilaria Vicenti[SUP] 2 [/SUP], Francesca Gatti[SUP] 1 [/SUP], Renzo Scaggiante[SUP] 3 [/SUP], Lia Fiaschi[SUP] 2 [/SUP], Federica Giammarino[SUP] 2 [/SUP], Marco Iannetta[SUP] 4 [/SUP], Vincenzo Malagnino[SUP] 4 [/SUP], Daniela Zago[SUP] 1 5 [/SUP], Filippo Dragoni[SUP] 2 [/SUP], Maurizio Zazzi[SUP] 2 [/SUP]
Affiliations
- PMID: 36016125
- DOI: 10.3390/vaccines10081237
Abstract
We report the time course of neutralizing antibody (NtAb) response, as measured by authentic virus neutralization, in healthcare workers (HCWs) with a mild or asymptomatic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection diagnosed at the onset of the pandemic, with no reinfection throughout and after a three-dose schedule of the BNT162b2 mRNA vaccine with an overall follow-up of almost two years since infection. Forty-eight HCWs (median age 47 years, all immunocompetent) were evaluated: 29 (60.4%) were asymptomatic. NtAb serum was titrated at eight subsequent time points: T1 and T2 were after natural infection, T3 on the day of the first vaccine dose, T4 on the day of the second dose, T5, T6, and T7 were between the second and third dose, and T8 followed the third dose by a median of 34 days. NtAb titers at all postvaccination time points (T4 to T8) were significantly higher than all those at prevaccination time points (T1 to T3). The highest NtAb increase was following the first vaccine dose while subsequent doses did not further boost NtAb titers. However, the third vaccine dose appeared to revive waning immunity. NtAb levels were positively correlated at most time points suggesting an important role for immunogenetics.
Keywords: BNT162b2 mRNA vaccine; COVID-19; authentic virus neutralization; healthcare workers; long-term follow-up; mild or asymptomatic SARS-CoV-2 infection; no reinfection; third vaccine dose.